tallózása szerző szerint "Rózsás, Anita"

1-9 / 9

Apelin expression in human non-small cell lung cancer: Role in angiogenesis and prognosis

Berta, Judit; Kenessey, István; Dobos J; Tóvári, József; Klepetko W; Ankersmit HJ; Hegedűs, Balázs; Rényi-Vámos, Ferenc István; Varga, János; Lorincz Zs; Paku, Sándor; Ostoros, Gyula; Rózsás, Anita; Tímár, József; Döme, Balázs (2010)
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study

Hoda, M Alireza; Dong, Yawen; Rózsás, Anita; Klikovits, Thomas; László, Viktória; Bahil, Ghanim; Paul, Stockhammer; Judit, Ozsvar; Marko, Jakopovic; Miroslav, Samarzija; Luka, Brcic; Mátyás, Bendek; Ildikó, Szirtes; Glen, Reid; Michaela, B Kirschner; Steven, C Kao; Isabelle, Opitz; Walter, Weder; Thomas, Frauenfelder; Thi Dan Linh, Nguyen-Kim; Clemens, Aigner; Walter, Klepetko; Nico, van Zandwijk; Walter, Berger; Döme, Balázs; Michael, Grusch; Hegedűs, Balázs (2016)

INTRODUCTION: The deregulation of activin expression is often observed in various malignancies. Previous studies indicate that activin A plays a protumourigenic role in malignant pleural mesothelioma (MPM). The aim of the ...
Epigenetic down-regulation of integrin alpha7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma

Laszlo V; Hoda MA; Garay, Tamás; Pirker C; Ghanim B; Klikovits T; Dong YW; Rózsás, Anita; Kenessey, István; Szirtes, Ildikó; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zochbauer-Muller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Döme, Balázs; Hegedűs, Balázs (2015)

Malignant pleural mesothelioma (MPM) is a devastating malignancy characterized by invasive growth and rapid recurrence. The identification and inhibition of molecular components leading to this migratory and invasive ...
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

Kirschner MB; Pulford E; Hoda MA; Rózsás, Anita; Griggs K; Cheng YY; Edelman JJ; Kao SC; Hyland R; Dong Y; Laszlo V; Klikovits T; Vallely MP; Grusch M; Hegedűs, Balázs; Döme, Balázs; Klepetko W; van Zandwijk N; Klebe S; Reid G (2015)

BACKGROUND: Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies. METHODS: ELISA was used to measure cellular and ...
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma

Hoda, M Alireza; Rózsás, Anita; Lang, Elisabeth; Klikovits, Thomas; Lohinai, Zoltán; Török , Szilvia; Berta, Judit; Mátyás, Bendek; Walter, Berger; Hegedűs, Balázs; Walter, Klepetko; Rényi-Vámos, Ferenc István; Michael, Grusch; Döme, Balázs; Viktória, László (2016)

Activin A (ActA)/follistatin (FST) signaling has been shown to be deregulated in different tumor types including lung adenocarcinoma (LADC). Here, we report that serum ActA protein levels are significantly elevated in ...
Localization of sunitinib, its metabolites and its target receptors in tumour bearing mice: a MALDI mass spectrometry imaging study

Török, Szilvia; Vegvari A; Rezeli M; Fehniger TE; Tóvári, József; Paku, Sándor; Laszlo, Viktoria; Hegedűs, Balázs; Rózsás, Anita; Döme, Balázs; Marko-Varga G (2015)

BACKGROUND AND PURPOSE: The clinical impact of antiangiogenic agents remains controversial. Therefore, elucidating the pharmacological properties of these compounds is a pivotal issue. EXPERIMENTAL APPROACH: In our study, ...
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy

Cserepes, Mihály; Ostoros, Gyula; Lohinai, Zoltán; Rásó, Erzsébet; Barbai, Tamás; Tímár, József; Rózsás, Anita; Moldvay, Judit; Kovalszky, Ilona; Fábián, Katalin; Gyulai, Márton; Ghanim, Bahil; László, Viktória; Thomas, Klikovits; Hoda, Mir Alireza; Grusch, Michael; Berger, Walter; Klepetko, Walter; Hegedűs, Balázs; Döme, Balázs (2014)

Background: Platinum-based chemotherapy is the most common treatment in advanced-stage lung adenocarcinoma. Because the clinical significance of KRAS mutational status in this setting has not yet been clearly determined, ...
Szemelvények a Semmelweis Egyetem, az Országos Onkológiai Intézet és az Országos Korányi Tbc és Pulmonológiai Intézet együttműködésén alapuló tüdőrák-kutatási programból

Hegedűs, Balázs; Moldvay, Judit; Berta, Judit; Lohinai, Zoltán; Rózsás, Anita; Cserepes, Tamás Mihály; Fábián, Katalin; Ostoros G; Tóvári, József; Rényi-Vámos, Ferenc István; Tímár, József; Döme, Balázs (2015)

Lung cancer places a significant socio-economic burden on the Hungarian population. This overview summarizes the findings of collaborative translational lung cancer research efforts of three Hungarian flagship academic ...
Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and bcl-2 inhibition in vitro

Hoda, Mir A; Pirker, Christine; Dong, Yawen; Schelch, Karin; Heffeter, Petra; Kushtrim, Kryeziu; Sushilla, van Schoonhoven; Thomas, Klikovits; László, Viktória; Rózsás, Anita; Ozsvár, Judit; Walter, Klepetko; Döme, Balázs; Michael, Grusch; Hegedűs, Balázs; Walter, Berger (2016)

Malignant pleural mesothelioma (MPM) is characterized by widespread resistance to systemic therapy. Trabectedin is an antineoplastic agent targeting both the malignant cells and the tumor microenvironment which has been ...

1-9 / 9

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Rózsás, Anita"

DSpace/Manakin Repository

tallózása szerző szerint "Rózsás, Anita"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem